|
|
| MRD / Regn No. |
: MH/23-24/01073 |
Date |
: 08/07/2026 |
| Patient Name |
: MR ABDULLASHA |
Age & Gender |
: 33 Yrs. / Male |
| Contact No. |
: 6383356604 |
UHID |
: |
| Ht / Wt / BMI |
: / 76 / |
BP S / BP D |
: 129 / 89 |
| Allergies |
: NO ALLERGIES |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM - UNCONTROLLED (23/Apr/2024) | |
|
Subjective |
: |
NUMBNESS LEFT FOOT |
| Salient Investigations |
: |
HB HEMOGLOBIN: 15.7 g/dL | UREA: 26 mg/dL | CREATININE: 1.0 1 | EGFR EGLOMERULAR FILTRATION RATE: 91.66 mL/min/1.73m2 | URIC ACID: 6.1 | FASTING PLASMA GLUCOSE (FPG): 283 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 346 100 | TOTAL BILIRUBIN: 0.6 mg/dL | DIRECT BILIRUBIN: 0.2 mg/DL | INDIRECT BILURUBIN: 0.4 | TOTAL CHOLESTEROL: 299 1 | TGL TRIGLYCERIDE: 602 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 52 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 121 mg/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET VILDAGLIPTIN
VILDAR 50
Medicine For DIABETES |
ORAL |
1-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
2 |
TABLET GLIMEPRIDE 2 +METFORMIN 500 + VOGLIBOSE 0.2
GLIMIWINDAR TRIO 2 |
ORAL |
1-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
3 |
TABLET DAPAGLIFLOZIN 10+ PIOGLITAZONE 15MG
DAPAZIO PRO |
|
0-0-1 |
AFTER FOOD
|
|
|
|
4 |
TABLET ROSUVASTATIN 10
ROSUWIN 10 |
ORAL |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
5 |
CAPSULE ROSUVASTATIN 5 + FENOFIBRATE 16.5MG
ROSUVAS F |
|
0-0-1 |
|
|
|
|
6 |
TABLET METHYLCOBALAMIN+ MINERALS+VITAMINS
RENEW BT
Medicine For GENE HEALTH |
ORAL |
1-0-0 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 07/Aug/2026 |
| Tests Suggested For Next Visit |
: FASTING SUGAR,POST PRANDIAL SUGAR,HBA1C |
| |
|
| |
|
